Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|48|10|2741-2749

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.48, Iss.10, 2003-10, pp. : 2741-2749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potent Inhibitory Effect of ?-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis

By  

Current Drug Discovery Technologies, Vol. 14, Iss. 3, 2017-08 ,pp. : 206-214

Bentham Science Publishers

Access to resources Recommend Favorite

Relatives Without Rheumatoid Arthritis Show Reactivity to Anti–Citrullinated Protein/Peptide Antibodies That Are Associated With Arthritis‐Related Traits: Studies of the Etiology of Rheumatoid Arthritis

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1995-2004

John Wiley & Sons Inc

Access to resources Recommend Favorite

Citrullinated Peptides in the Diagnosis of Rheumatoid Arthritis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 743-751

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Citrullinated Peptides for the Diagnosis and Prognosis of Rheumatoid Arthritis

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 23, 2014-12 ,pp. : 2729-2733

Bentham Science Publishers

Access to resources Recommend Favorite

Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2701-2705

John Wiley & Sons Inc

Access to resources Recommend Favorite